Carealytix is dedicated to transforming chronic disease management through innovative digital solutions tailored for modern healthcare. They focus on providing personalized care for individuals living with chronic conditions by creating user-centric, data-driven digital products.

With a primary emphasis on kidney care, their flagship digital care platform supports patients throughout their journey by offering education, health tracking, and enabling data sharing with healthcare providers. Their products include the Mizu app, a leading solution for chronic kidney disease (CKD) patients, and Kidney+, a hybrid care program that offers telecoaching and lifestyle coaching to support patients in between doctor's visits.

Carealytix aims to eliminate gaps in healthcare by streamlining clinical workflows, improving patient-physician interactions, and enhancing healthcare team efficiency. Their solutions facilitate patient engagement, accelerate health research and innovation, and focus on integrated, interdisciplinary care for chronic diseases. The company emphasizes regulatory compliance, being ISO-13485 certified, GDPR compliant, and EU-MDR certified for software-as-a-medical-device.